The Chinese disease in the news

[Legion]

COULD IT PROVE FATAL?

Last October, Johnson & Johnson paused its vaccine trial when a participant became ill. It resumed the trial about two weeks later, saying there was "no evidence" that the vaccine had caused the illness.

Publicly, the nature of the participant's illness remained a mystery until February, when the FDA revealed that a 25-year-old male study participant with no past medical history and who wasn't taking any medications received the vaccine and experienced a transverse sinus thrombosis.

About 3 to 4 people per 1 million experience this blood clot each year, and 75% of the adult cases are women, according to a 2005 study in the New England Journal of Medicine.

During Johnson & Johnson's clinical trial, there were reports of other types of blood clots, too. Some are relatively common, such as deep vein thrombosis, so it wasn't surprising that among roughly 20,000 participants who received the vaccine, some would experience those clots.

What made FDA scientists take note, however, is that in the trial, about the same number of people received a placebo -- a shot of saline that does nothing -- as received the vaccine.

However, when comparing the two groups, more study participants developed clots after receiving the vaccine than the placebo.

The FDA released a statement last week that it was aware of reports of "serious thromboembolic events" in the US that occurred "in a few individuals following receipt of the [Johnson & Johnson] COVID-19 vaccine" and that "at this time we have not found a causal relationship with vaccination."

This isn't the first time blood clots have come up in relation to a Covid-19 vaccine. The J&J vaccine and the AstraZeneca vaccines are similar -- they both use adenovirus vectors to make them work.

The European Medicines Agency noted that most of these people experienced a type of blood clot in the brain called cerebral venous sinus thrombosis. Transverse sinus thrombosis -- the clot experienced by the young participant in the Johnson & Johnson trial -- is a type of cerebral venous sinus thrombosis.

The agency noted that its safety committee reviewed 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis, a type of blood clot in the abdomen, 18 of which were fatal.



https://edition.cnn.com/2021/04/13/health/johnson-vaccine-pause-cdc-fda/index.html

[Darth Omar]

The [probably man made] protein spike in Covid is what causes the multifocal thrombosis in severe Covid cases. The ‘vaccines’ which prompt the body to produce a spike analog—can have the same effect, apparently.

Interesting that it seems to affect young women. Young women that have little to fear from the CCP Virus.

[Legion]

The [probably man made] protein spike in Covid is what causes the multifocal thrombosis in severe Covid cases. The ‘vaccines’ which prompt the body to produce a spike analog—can have the same effect, apparently. Interesting that it seems to affect young women. Young women that have little to fear from the CCP Virus.

Hope springs eternal, lol.